# RACE ONCOLOGY LTD

> Australian public company

**Wikidata**: [Q109627104](https://www.wikidata.org/wiki/Q109627104)  
**Source**: https://4ort.xyz/entity/race-oncology-ltd

## Summary

RACE ONCOLOGY LTD is an Australian public company listed on the Australian Securities Exchange (ASX) under the ticker symbol RAC. The company has been traded on the ASX since July 13, 2016, and as of November 18, 2021, had a market capitalization of 505,461,363 Australian dollars. As a public company, RACE ONCOLOGY LTD offers its securities for sale to the general public, allowing anyone to purchase ownership stakes in the company through the stock exchange.

## Key Facts

- **Official Name**: RACE ONCOLOGY LTD
- **Entity Classification**: Public company — a corporation that offers its securities for sale to the general public
- **Stock Exchange**: Australian Securities Exchange (ASX)
- **Ticker Symbol**: RAC
- **Listing Date**: July 13, 2016
- **Market Capitalization**: 505,461,363 AUD (as of November 18, 2021)
- **Country**: Australia
- **Wikidata Description**: Australian public company

## FAQs

**What type of company is RACE ONCOLOGY LTD?**

RACE ONCOLOGY LTD is a public company incorporated in Australia and listed on the Australian Securities Exchange. As a public company, it differs from a private company in that its shares are traded openly on a public market, allowing any member of the general public to become a shareholder.

**Where is RACE ONCOLOGY LTD traded and what is its ticker symbol?**

RACE ONCOLOGY LTD is traded on the Australian Securities Exchange under the ticker symbol RAC. The company listed on the ASX on July 13, 2016.

**How large is RACE ONCOLOGY LTD according to market capitalization?**

As of November 18, 2021, RACE ONCOLOGY LTD had a market capitalization of 505,461,363 Australian dollars, representing the total value of all its publicly traded shares.

**What does being a "public company" mean for RACE ONCOLOGY LTD?**

As a public company, RACE ONCOLOGY LTD has the ability to raise capital by offering securities to the general public. This structure requires the company to adhere to strict regulatory disclosure and reporting standards, promoting transparency for investors. The company's ownership is distributed among public shareholders who can buy and sell their shares freely on the ASX.

## Why It Matters

RACE ONCOLOGY LTD represents a significant component of Australia's publicly traded corporate landscape. As an ASX-listed company, it provides Australian investors with opportunities to participate in the company's potential growth and success. The public company structure enables the firm to access capital from a wide pool of investors, facilitating business expansion, research and development, or other corporate initiatives. For investors, the company offers a mechanism for wealth creation, with the liquidity to easily buy and sell ownership stakes through the stock exchange. The company's listing on the ASX also subjects it to regulatory oversight that promotes transparency and protects investor interests, making it a relevant entity in the Australian financial ecosystem.

## Notable For

- Being listed on the Australian Securities Exchange, one of the world's major financial markets
- Trading under the ticker symbol RAC since July 2016
- Having a substantial market capitalization exceeding 505 million Australian dollars
- Representing the public company model of corporate organization, which is a fundamental pillar of modern capitalism in Australia

## Body

### Corporate Classification and Legal Structure

RACE ONCOLOGY LTD is classified as a public company, which is a specific type of joint-stock company and a distinct legal form of organization. This classification means the company offers its securities, such as stock, for sale to the general public. The public company structure is a fundamental pillar of modern capitalism, enabling large-scale capital formation for business expansion and growth. Unlike private companies, where shares are held by a closed group of investors, public companies like RACE ONCOLOGY LTD allow any member of the general public to become an owner by purchasing shares on the open market.

### Stock Exchange Listing and Trading

The company is listed on the Australian Securities Exchange (ASX), which is Australia's primary securities market. RACE ONCOLOGY LTD began trading on the ASX on July 13, 2016, under the ticker symbol RAC. The ASX is one of the world's major financial exchanges and provides a regulated marketplace for buying and selling listed securities. As a listed company on the ASX, RACE ONCOLOGY LTD is subject to the exchange's listing rules and regulatory requirements, which include ongoing disclosure obligations and corporate governance standards.

### Market Presence and Financial Metrics

As of November 18, 2021, RACE ONCOLOGY LTD had a market capitalization of 505,461,363 Australian dollars. Market capitalization represents the total market value of a company's outstanding shares and is calculated by multiplying the share price by the number of shares outstanding. This metric provides insight into the company's size and market valuation. The company's presence in the ASX directory indicates its active status as a publicly traded entity within the Australian market.

### Ownership and Governance Structure

As a public company, RACE ONCOLOGY LTD is owned by its shareholders, who can be individuals, institutional investors, or other entities that have purchased its publicly traded securities. The public company structure typically involves a separation of ownership (shareholders) and control (management and board of directors), which is a classic feature of the corporate structure. This governance model allows for professional management while giving shareholders voting rights on major corporate decisions.

### Distinction from Other Entity Types

RACE ONCOLOGY LTD, as a public company, is distinctly different from entities such as public enterprises or government agencies, which are state-owned. While a public company is privately owned but publicly traded, public enterprises are government-owned entities. The company is also different from private companies, whose shares are not publicly traded and are typically held by a smaller group of investors such as founders, family members, or venture capitalists.

### Regulatory Context

As an ASX-listed public company, RACE ONCOLOGY LTD operates within Australia's robust financial regulatory framework. Public companies are required to adhere to strict regulatory disclosure and reporting standards, which promotes transparency for investors. This regulatory environment helps protect investor interests and maintains confidence in the Australian financial markets. The company is included in the ASX directory, which tracks all listed securities and provides information about publicly traded companies operating in Australia.

## References

1. [Source](https://www2.asx.com.au/markets/trade-our-cash-market/directory)